Lower Forecast for Watson Pharmaceuticals

S&P cites GAAP accounting

Company: FMC Corp. (FMC )

Year ending: Dec-02

Prior estimate: 6.00

New estimate: 3.25

Rationale: Reflects recent spin-off

Company: Overseas Shipholding (OSG )

Year ending: Dec-02

Prior estimate: 2.28

New estimate: 0.79

Rationale: Weaker oil demand & prices

Company: Watson Pharmaceuticals (WPI )

Year ending: Dec-02

Prior estimate: 1.82

New estimate: 1.54

Rationale: Reflects GAAP accounting

JAN. 3

Company: Inco Ltd. (N )

Year ending: Dec-02

Prior estimate: 1.50

New estimate: 0.80

Rationale: Reflects lingering weak nickel prices

Company: Pacificare (PHSY )

Year ending: Dec-02

Prior estimate: 2.00

New estimate: 3.60

Rationale: Change in goodwill accounting

    Before it's here, it's on the Bloomberg Terminal.
    LEARN MORE